MB
BMY icon

MidFirst Bank’s Bristol-Myers Squibb BMY Stock Holding History

MidFirst Bank’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.5K Hold
443
– – ﹤0.01% 448
2026
Q1 		$26.9K Sell
443
-7,570
-94% -$441K ﹤0.01% 446
2025
Q4 		$16.9K Buy
+8,013
New +$385K ﹤0.01% 549

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

MidFirst Bank's BMY Position: Q2 2026 in Review

MidFirst Bank held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 443 shares worth $25.5K. The position accounts for ﹤0.01% of the portfolio, ranked #448.

MidFirst Bank first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $26.9K in Q1 2026. 2,173 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • MidFirst Bank held 443 shares of Bristol-Myers Squibb worth $25.5K as of Q2 2026.
  • MidFirst Bank left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up ﹤0.01% of MidFirst Bank's portfolio in Q2 2026, its #448 holding.
  • MidFirst Bank first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • MidFirst Bank's Bristol-Myers Squibb position peaked at $26.9K in Q1 2026.
  • 2,173 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on MidFirst Bank's 13F filing for Q2 2026, filed 7 Aug 2026.